These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 17415381

  • 1. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.
    Wu A, Oh S, Ericson K, Demorest ZL, Vengco I, Gharagozlou S, Chen W, Low WC, Ohlfest JR.
    Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381
    [Abstract] [Full Text] [Related]

  • 2. Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.
    Ohlfest JR, Lobitz PD, Perkinson SG, Largaespada DA.
    Mol Ther; 2004 Aug; 10(2):260-8. PubMed ID: 15294173
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lung-directed gene therapy in mice using the nonviral Sleeping Beauty transposon system.
    Belur LR, Podetz-Pedersen K, Frandsen J, McIvor RS.
    Nat Protoc; 2007 Aug; 2(12):3146-52. PubMed ID: 18079714
    [Abstract] [Full Text] [Related]

  • 5. Hyperactive transposase mutants of the Sleeping Beauty transposon.
    Baus J, Liu L, Heggestad AD, Sanz S, Fletcher BS.
    Mol Ther; 2005 Dec; 12(6):1148-56. PubMed ID: 16150650
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stable gene transfer to human CD34(+) hematopoietic cells using the Sleeping Beauty transposon.
    Hollis RP, Nightingale SJ, Wang X, Pepper KA, Yu XJ, Barsky L, Crooks GM, Kohn DB.
    Exp Hematol; 2006 Oct; 34(10):1333-43. PubMed ID: 16982326
    [Abstract] [Full Text] [Related]

  • 9. Sleeping Beauty-mediated transposition and long-term expression in vivo: use of the LoxP/Cre recombinase system to distinguish transposition-specific expression.
    Score PR, Belur LR, Frandsen JL, Geurts JL, Yamaguchi T, Somia NV, Hackett PB, Largaespada DA, McIvor RS.
    Mol Ther; 2006 Mar; 13(3):617-24. PubMed ID: 16356773
    [Abstract] [Full Text] [Related]

  • 10. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
    Converse AD, Belur LR, Gori JL, Liu G, Amaya F, Aguilar-Cordova E, Hackett PB, McIvor RS.
    Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression.
    Mitsui M, Nishikawa M, Zang L, Ando M, Hattori K, Takahashi Y, Watanabe Y, Takakura Y.
    J Gene Med; 2009 May; 11(5):435-43. PubMed ID: 19291673
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes.
    Badea I, Verrall R, Baca-Estrada M, Tikoo S, Rosenberg A, Kumar P, Foldvari M.
    J Gene Med; 2005 Sep; 7(9):1200-14. PubMed ID: 15895387
    [Abstract] [Full Text] [Related]

  • 16. Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma.
    Ohlfest JR, Demorest ZL, Motooka Y, Vengco I, Oh S, Chen E, Scappaticci FA, Saplis RJ, Ekker SC, Low WC, Freese AB, Largaespada DA.
    Mol Ther; 2005 Nov; 12(5):778-88. PubMed ID: 16150649
    [Abstract] [Full Text] [Related]

  • 17. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates.
    Izsvák Z, Ivics Z, Plasterk RH.
    J Mol Biol; 2000 Sep 08; 302(1):93-102. PubMed ID: 10964563
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma receptor/IgG1 fusion protein.
    Prud'homme GJ, Chang Y.
    Gene Ther; 1999 May 08; 6(5):771-7. PubMed ID: 10505100
    [Abstract] [Full Text] [Related]

  • 20. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
    Shiau AL, Lin CY, Tzai TS, Wu CL.
    Cancer Gene Ther; 2001 Jan 08; 8(1):73-81. PubMed ID: 11219496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.